Cinclus Pharma’s CEO Christer Ahlberg in an interview with Redeye about the Phase III study and the Q3 report

Cinclus News Image Christer Redeye

Redeye has interviewed Cinclus Pharma’s CEO, Christer Ahlberg, about the company’s recently initiated Phase III study with linaprazan glurate and the company’s Q3 report.

Watch the full interview (in Swedish).

Back